Skip to content

Cythereal

Small malware-analysis vendor whose MAGIC technology correlates malware samples genomically to predict and investigate related attack campaigns.

Visit Website ↗ + Add to Compare
35/100Emerging / Unranked

Overview

Cythereal builds malware analysis technology called MAGIC (Malware Genomic Correlation) that treats malware samples the way genomic analysis treats DNA — comparing code lineage across samples to identify variants of known malware families, generate custom indicators of compromise, and help investigate failed or attempted attacks that other tools might dismiss as noise. The product is delivered as a cloud service (MAGIC EWS, an early-warning system) or on-premises appliance, integrating with existing antivirus, endpoint detection, threat intelligence, and SIEM tools rather than replacing them.

Founded in 2016 by University of Louisiana at Lafayette computer science professor Arun Lakhotia, Cythereal is headquartered in Lafayette, Louisiana, and grew out of academic malware-genomics research. The company’s technology has been referenced in peer-reviewed security research on malware lineage and clustering.

Cythereal is a small company with limited recent public activity — its website copyright and visible content suggest it has not been aggressively updated in the past few years, and no recent funding, partnership, or customer announcements were found. The underlying malware-genomics approach is technically credible and academically grounded, but the company shows fewer signs of current market momentum than more actively marketed threat-intelligence vendors.

Innovation Matrix Assessment

Innovation Velocity 3/10

Website content and copyright notices indicate limited recent updates, and no product releases, funding, or partnership announcements were found in the past few years, suggesting a slow current pace of visible development.

Operational Value 5/10

MAGIC's genomic-correlation approach to malware analysis is a real, deployable technique (available as SaaS or on-prem appliance) that integrates with existing AV, EDR, and SIEM tools, though evidence of broad current deployment is limited.

Market Momentum 2/10

No recent funding rounds, new customer announcements, or press coverage were found; independent trackers describe activity levels as low compared to peer companies in the same sector.

Category Disruption 4/10

The malware-genomics correlation concept, grounded in the founder's academic research, is a distinctive technical angle on malware family clustering rather than a conventional signature- or ML-classifier approach, though it has not visibly scaled or been widely adopted.

Real-World Efficacy 3/10

The technique has academic grounding and has been referenced in peer-reviewed malware-lineage research, but no independent, current third-party efficacy testing or named enterprise customer results were found.

Enduring Relevance 4/10

Malware family attribution and correlation remain useful for threat investigation, but the company's low recent visibility limits confidence that this specific offering is currently well-positioned against more actively developed threat-intelligence platforms.

Why CISOs Should Care

Offers a distinctive genomic-correlation method for tracing malware variants back to known families, useful for investigating failed attacks that other tools might otherwise dismiss.

What Makes It Different

Applies a genomic/lineage-comparison technique to malware samples, rooted in the founder's academic research, rather than a conventional signature- or purely ML-based classifier.

The Matrix Verdict

35/100 — EMERGING / UNRANKED

A technically credible, academically grounded malware-analysis approach that appears to have limited current commercial momentum; scored to reflect real but largely unverifiable current-state evidence.

Editorial Note: Claims vs. Verified Findings

Evidence of current operations is limited: the company website (copyright 2022) is live with an active free-trial link, but independent trackers report low recent activity and no funding or customer news was found for 2024-2025. Academic references to the MAGIC/malware-genome concept are independently verifiable; specific product efficacy and customer-scale claims are not.

Sources